Callan Family Office LLC bought a new position in shares of Colgate-Palmolive (NYSE:CL - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 6,750 shares of the company's stock, valued at approximately $614,000.
Other institutional investors also recently modified their holdings of the company. Kohmann Bosshard Financial Services LLC purchased a new stake in Colgate-Palmolive in the 4th quarter valued at $26,000. Centricity Wealth Management LLC purchased a new stake in Colgate-Palmolive in the 4th quarter valued at $27,000. Union Bancaire Privee UBP SA purchased a new stake in Colgate-Palmolive in the 4th quarter valued at $32,000. Bernard Wealth Management Corp. purchased a new stake in Colgate-Palmolive in the 4th quarter valued at $36,000. Finally, Roxbury Financial LLC purchased a new stake in shares of Colgate-Palmolive during the 4th quarter valued at $43,000. 80.41% of the stock is owned by institutional investors and hedge funds.
Colgate-Palmolive Price Performance
Colgate-Palmolive stock traded up $0.72 during midday trading on Monday, reaching $97.46. 9,790,594 shares of the stock were exchanged, compared to its average volume of 4,160,466. The company's fifty day moving average is $88.84 and its 200-day moving average is $95.11. The company has a debt-to-equity ratio of 13.40, a quick ratio of 0.58 and a current ratio of 0.92. The firm has a market cap of $79.09 billion, a PE ratio of 27.69, a PEG ratio of 4.20 and a beta of 0.40. Colgate-Palmolive has a 52 week low of $85.32 and a 52 week high of $109.30.
Colgate-Palmolive (NYSE:CL - Get Free Report) last posted its earnings results on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, topping analysts' consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same quarter last year, the firm posted $0.87 EPS. On average, sell-side analysts forecast that Colgate-Palmolive will post 3.75 EPS for the current year.
Colgate-Palmolive Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Friday, February 14th. Investors of record on Tuesday, January 21st were issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 2.05%. The ex-dividend date of this dividend was Tuesday, January 21st. Colgate-Palmolive's dividend payout ratio (DPR) is presently 56.82%.
Wall Street Analyst Weigh In
CL has been the subject of several research reports. TD Cowen reduced their price target on shares of Colgate-Palmolive from $110.00 to $100.00 and set a "buy" rating for the company in a research report on Wednesday, January 8th. Wells Fargo & Company dropped their target price on shares of Colgate-Palmolive from $92.00 to $83.00 and set an "underweight" rating on the stock in a research note on Tuesday, January 7th. Morgan Stanley dropped their target price on shares of Colgate-Palmolive from $111.00 to $104.00 and set an "overweight" rating on the stock in a research note on Monday, February 3rd. Barclays dropped their target price on shares of Colgate-Palmolive from $96.00 to $83.00 and set an "equal weight" rating on the stock in a research note on Friday, January 17th. Finally, Piper Sandler dropped their target price on shares of Colgate-Palmolive from $121.00 to $112.00 and set an "overweight" rating on the stock in a research note on Monday, January 6th. One analyst has rated the stock with a sell rating, nine have issued a hold rating and twelve have assigned a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $101.61.
Read Our Latest Research Report on Colgate-Palmolive
About Colgate-Palmolive
(
Free Report)
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Featured Stories
Before you consider Colgate-Palmolive, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.
While Colgate-Palmolive currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
